Literature DB >> 20567820

Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT.

Barbara Palumbo1, Mario Luca Fravolini, Susanna Nuvoli, Angela Spanu, Kai Stephan Paulus, Orazio Schillaci, Giuseppe Madeddu.   

Abstract

PURPOSE: To contribute to the differentiation of Parkinson's disease (PD) and essential tremor (ET), we compared two different artificial neural network classifiers using (123)I-FP-CIT SPECT data, a probabilistic neural network (PNN) and a classification tree (ClT).
METHODS: (123)I-FP-CIT brain SPECT with semiquantitative analysis was performed in 216 patients: 89 with ET, 64 with PD with a Hoehn and Yahr (H&Y) score of ≤2 (early PD), and 63 with PD with a H&Y score of ≥2.5 (advanced PD). For each of the 1,000 experiments carried out, 108 patients were randomly selected as the PNN training set, while the remaining 108 validated the trained PNN, and the percentage of the validation data correctly classified in the three groups of patients was computed. The expected performance of an "average performance PNN" was evaluated. In analogy, for ClT 1,000 classification trees with similar structures were generated.
RESULTS: For PNN, the probability of correct classification in patients with early PD was 81.9±8.1% (mean±SD), in patients with advanced PD 78.9±8.1%, and in ET patients 96.6±2.6%. For ClT, the first decision rule gave a mean value for the putamen of 5.99, which resulted in a probability of correct classification of 93.5±3.4%. This means that patients with putamen values >5.99 were classified as having ET, while patients with putamen values <5.99 were classified as having PD. Furthermore, if the caudate nucleus value was higher than 6.97 patients were classified as having early PD (probability 69.8±5.3%), and if the value was <6.97 patients were classified as having advanced PD (probability 88.1%±8.8%).
CONCLUSION: These results confirm that PNN achieved valid classification results. Furthermore, ClT provided reliable cut-off values able to differentiate ET and PD of different severities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567820     DOI: 10.1007/s00259-010-1481-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  11 in total

1.  Artificial neural network classifier for the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.

Authors:  Paul D Acton; Andrew Newberg
Journal:  Phys Med Biol       Date:  2006-05-31       Impact factor: 3.609

2.  EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.

Authors:  Koen Van Laere; Andrea Varrone; Jan Booij; Thierry Vander Borght; Flavio Nobili; Ozlem L Kapucu; Zuzana Walker; Kjell Någren; Klaus Tatsch; Jacques Darcourt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 9.236

3.  Classification of mild Alzheimer's disease by artificial neural network analysis of SPET data.

Authors:  D Hamilton; D O'Mahony; J Coffey; J Murphy; N O'Hare; P Freyne; B Walsh; D Coakley
Journal:  Nucl Med Commun       Date:  1997-09       Impact factor: 1.690

4.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123 I]-FP-CIT SPECT imaging: The [123 I]-FP-CIT study group.

Authors:  Hani T S Benamer; Jim Patterson; Donald G Grosset; J Booij; K de Bruin; E van Royen; J D Speelman; M H I M Horstink; H J W A Sips; R A Dierckx; J Versijpt; D Decoo; C Van Der Linden; D M Hadley; M Doder; A J Lees; D C Costa; S Gacinovic; W H Oertel; O Pogarell; H Hoeffken; K Joseph; K Tatsch; J Schwarz; V Ries
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data.

Authors:  David Hamilton; Adrian List; Timothy Butler; Stephen Hogg; Martin Cawley
Journal:  Nucl Med Commun       Date:  2006-12       Impact factor: 1.690

Review 7.  Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

Authors:  G Deuschl; P Bain; M Brin
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

8.  Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy.

Authors:  Angelo Antonini; Patrizia Berto; Stefania Lopatriello; Filippo Tamma; Lieven Annemans; Mike Chambers
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

9.  Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity.

Authors:  Siegbert Warkentin; Mattias Ohlsson; Per Wollmer; Lars Edenbrandt; Lennart Minthon
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

Review 10.  Role of dopamine transporter imaging in routine clinical practice.

Authors:  Vicky Marshall; Donald Grosset
Journal:  Mov Disord       Date:  2003-12       Impact factor: 10.338

View more
  9 in total

1.  Comparative analysis of four disease prediction models of Parkinson's disease.

Authors:  Nadella Kumudini; Shaik Mohammad Naushad; Balraj Alex Stanley; Manoharan Niveditha; Gunasekaran Sharmila; Konda Kumaraswami; Rupam Borghain; Rukmini Mridula; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2015-10-05       Impact factor: 3.396

2.  [123I]Metaiodobenzylguanidine (MIBG) Cardiac Scintigraphy and Automated Classification Techniques in Parkinsonian Disorders.

Authors:  Susanna Nuvoli; Angela Spanu; Mario Luca Fravolini; Francesco Bianconi; Silvia Cascianelli; Giuseppe Madeddu; Barbara Palumbo
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

3.  Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?

Authors:  Shonit Punwani; Stuart A Taylor; Ziauddin Z Saad; Alan Bainbridge; Ashley Groves; Stephen Daw; Ananth Shankar; Steve Halligan; Paul D Humphries
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-30       Impact factor: 9.236

4.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

5.  Diagnostic accuracy of Parkinson disease by support vector machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age.

Authors:  Barbara Palumbo; Mario Luca Fravolini; Tommaso Buresta; Filippo Pompili; Nevio Forini; Pasquale Nigro; Paolo Calabresi; Nicola Tambasco
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?

Authors:  Jonathan Christopher Taylor; John Wesley Fenner
Journal:  EJNMMI Phys       Date:  2017-11-29

7.  Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting.

Authors:  Jonathan Christopher Taylor; Charles Romanowski; Eleanor Lorenz; Christine Lo; Oliver Bandmann; John Fenner
Journal:  EJNMMI Res       Date:  2018-05-08       Impact factor: 3.138

8.  Assessment of the Status of Patients with Parkinson's Disease Using Neural Networks and Mobile Phone Sensors.

Authors:  Yulia Shichkina; Elizaveta Stanevich; Yulia Irishina
Journal:  Diagnostics (Basel)       Date:  2020-04-12

Review 9.  Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson's disease.

Authors:  Jing Zhang
Journal:  NPJ Parkinsons Dis       Date:  2022-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.